Our Liposomal Glutathione is formulated with this exact science in mind, prioritizing purity and the highest possible absorption rates
Below, we review the current landscape of oral GLP-1 drugs, how they work, and how they compare to their injectable counterparts
Long-term impact on total cost of care also remains to be seen. Employer groups are wondering if employees who are taking the drug for diabetes will be on them indefinitely, creating a costly, new, long-term budget concern with lingering questions about any savings from reductions in obesity-related illness
While several CVOTs were performed with injectable GLP-1 RAs [46], the recent SOUL trial assessed the use of oral semaglutide, which was associated with a significantly lower risk of MACE than a placebo, without an increase in the incidence of serious adverse events, in patients with T2D and atherosclerotic cardiovascular disease (ASCVD), CKD, or both [71]